NR1H4 and metabolic dysfunction-associated steatotic liver disease: Taken together, increased levels of DCA, an antagonist of FXR, and decreased levels of the agonisticCDCA in NAFLD can lead to antagonizing FXR signaling and activation of NF-κB, potentially impacting the thioredoxin antioxidant system (Figure 7).